Altium Capital Management LP - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 56 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,410,000
-16.4%
775,0000.0%0.63%
-5.5%
Q2 2021$2,883,000
+7.5%
775,0000.0%0.67%
-10.1%
Q1 2021$2,682,000775,0000.74%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 1,607,044$5,400,0000.70%
NEA Management Company, LLC 6,643,704$22,323,0000.59%
DAFNA Capital Management LLC 320,542$1,077,0000.32%
Platform Technology Partners 141,025$474,0000.23%
Parkman Healthcare Partners LLC 110,547$371,0000.10%
Rock Springs Capital Management LP 1,314,374$4,416,0000.09%
GSA CAPITAL PARTNERS LLP 140,341$472,0000.08%
SABBY MANAGEMENT, LLC 65,000$218,0000.04%
Virtu Financial LLC 28,821$97,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,600$429,0000.01%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders